Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis
- 7 June 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 294 (2) , 441-447
- https://doi.org/10.1016/s0006-291x(02)00496-5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Chymase as a Proangiogenic FactorJournal of Biological Chemistry, 2000
- The implications of angiogenesis for the biology and therapy of cancer metastasisCell, 1994
- Analysis of experimental antiangiogenic therapyJournal of Pediatric Surgery, 1993
- Nonpeptide angiotensin II receptor antagonistsTrends in Pharmacological Sciences, 1991
- Isolation of a cDNA encoding the vascular type-1 angiotensin II receptorNature, 1991
- Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptorNature, 1991
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- The differential expression of H‐2K versus H‐2D antigens, distinguishing high‐ metastatic from low‐ metastatic clones, is correlated with the immunogenic properties of the tumor cellsInternational Journal of Cancer, 1984
- Anti-AngiogenesisAnnals of Surgery, 1972